Sign In
Buy ILMN
$168.06
-2.87 (-1.68%)
At Close: Jun 04, 2026
Illumina, Inc. (ILMN) Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)
06:24am, Tuesday, 10'th Jan 2023
Start Time: 18:45 January 1, 0000 7:20 PM ET Illumina, Inc. (NASDAQ:ILMN ) 41st Annual J.P. Morgan Healthcare Conference January 09, 2022, 18:45 PM ET Company Participants Francis deSouza - President
Jim Cramer says these 5 Nasdaq losers could rebound in 2023
07:24pm, Friday, 06'th Jan 2023
Cramer offered investors a list of Nasdaq stocks he believes could make a comeback this year.
Illumina: A Growth Stock in Waiting
11:13am, Wednesday, 04'th Jan 2023
Spinning off is easy, getting back together is hard—at least if you are trying to do it under the wary eyes of regulators on two continents.
New Strong Sell Stocks for January 4th
09:02am, Wednesday, 04'th Jan 2023
AVAH, CBRL and ILMN have been added to the Zacks Rank #5 (Strong Sell) List on January 4, 2023.
5 Toxic Stocks That Can Set Off Alarm Bells for Your Portfolio
08:17am, Wednesday, 04'th Jan 2023
Investors who can correctly spot overpriced stocks and shun them at the right time can avoid big losses. Dump toxic stocks like MGM, ILMN, OMCL, HL and RDNT to prevent portfolio bleeding.
Mutual Funds Are Investing In 'Survivors' For 2023
07:00am, Friday, 30'th Dec 2022
Stock picking is an art in a tough market. Learn which companies mutual fund managers believe can grow during economic uncertainty.
Illumina To Webcast Upcoming Investor Conference
04:05pm, Monday, 19'th Dec 2022
SAN DIEGO , Dec. 19, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: 41st Annual J.P. Morgan Healthcare Co
Is Illumina Cheap or Expensive?
10:57am, Wednesday, 14'th Dec 2022
It depends on which numbers you focus on.
Illumina: Strong EPS Growth Expected, But Shares Richly Valued In A Risky Space
06:42pm, Friday, 09'th Dec 2022
Biotech stocks notched multi-month highs earlier in December but then fell back in a possible bearish false breakout. Shares of one of the fund's biggest holdings is stuck in a consolidation after a b
EU Tells Illumina How to Unwind Deal to Buy Cancer-Test Developer Grail
10:54am, Monday, 05'th Dec 2022
The European Commission said Illumina will have to restore Grail's independence and return it to the same level that existed before the acquisition.
Illumina, Inc. (ILMN) Presents at Piper Sandler 34th Annual Healthcare Conference (Transcript)
11:37am, Wednesday, 30'th Nov 2022
Illumina, Inc. (NASDAQ:ILMN ) Piper Sandler 34th Annual Healthcare Conference November 30, 2022 9:00 AM ET Company Participants Francis deSouza - President & Chief Executive Officer Conference Call Pa
Illumina, Inc. (ILMN) Presents at Evercore ISI HealthCONx Conference (Transcript)
02:57pm, Tuesday, 29'th Nov 2022
Illumina, Inc. (NASDAQ:ILMN ) Evercore ISI HealthCONx Conference November 29, 2022 11:20 AM ET Company Participants Dr. Alex Aravanis - CTO Salli Schwartz - VP, IR Conference Call Participants Vijay K
Illumina CEO on the hunt to find Covid-19 variants
08:49am, Saturday, 19'th Nov 2022
Francis deSouza, CEO of Illumina, joins CNBC's Meg Tirrell to discuss the company's earnings and business into Covid-19 sequencing.
Illumina To Webcast Upcoming Investor Conferences
04:05pm, Tuesday, 15'th Nov 2022
SAN DIEGO , Nov. 15, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences: Evercore ISI HealthCONx Conference o
Illumina (ILMN) Q3 Earnings Beat Estimates, '22 View Slashed
12:03pm, Friday, 04'th Nov 2022
Delays in instruments and consumables purchases, negative foreign exchange impact and consumables inventory deleveraging are expected to impede growth in the rest of 2022 for Illumina (ILMN).
